Non-opioid Pain Patches Market - Global Outlook and Forecast 2022-2028
Report Code: KNJ1156359 No. of Pages: 76 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Non-opioid Pain Patches in global, including the following market information:
Global Non-opioid Pain Patches Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-opioid Pain Patches Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Non-opioid Pain Patches companies in 2021 (%)
The global Non-opioid Pain Patches market was valued at 649.7 million in 2021 and is projected to reach US$ 771.6 million by 2028, at a CAGR of 2.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lidocaine Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-opioid Pain Patches include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical and Teikoku Seiyaku, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-opioid Pain Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-opioid Pain Patches Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Non-opioid Pain Patches Market Segment Percentages, by Type, 2021 (%)
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Global Non-opioid Pain Patches Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Non-opioid Pain Patches Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Global Non-opioid Pain Patches Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Non-opioid Pain Patches Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-opioid Pain Patches revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-opioid Pain Patches revenues share in global market, 2021 (%)
Key companies Non-opioid Pain Patches sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Non-opioid Pain Patches sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
1 Introduction to Research & Analysis Reports
1.1 Non-opioid Pain Patches Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-opioid Pain Patches Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-opioid Pain Patches Overall Market Size
2.1 Global Non-opioid Pain Patches Market Size: 2021 VS 2028
2.2 Global Non-opioid Pain Patches Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Non-opioid Pain Patches Sales: 2017-2028
3 Company Landscape
3.1 Top Non-opioid Pain Patches Players in Global Market
3.2 Top Global Non-opioid Pain Patches Companies Ranked by Revenue
3.3 Global Non-opioid Pain Patches Revenue by Companies
3.4 Global Non-opioid Pain Patches Sales by Companies
3.5 Global Non-opioid Pain Patches Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Non-opioid Pain Patches Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Non-opioid Pain Patches Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-opioid Pain Patches Players in Global Market
3.8.1 List of Global Tier 1 Non-opioid Pain Patches Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-opioid Pain Patches Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-opioid Pain Patches Market Size Markets, 2021 & 2028
4.1.2 Lidocaine Patch
4.1.3 Diclofenac Patch
4.1.4 Methyl Salicylate Patch
4.1.5 Capsaicin Patch
4.1.6 Ketoprofen Patch
4.1.7 Others
4.2 By Type - Global Non-opioid Pain Patches Revenue & Forecasts
4.2.1 By Type - Global Non-opioid Pain Patches Revenue, 2017-2022
4.2.2 By Type - Global Non-opioid Pain Patches Revenue, 2023-2028
4.2.3 By Type - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
4.3 By Type - Global Non-opioid Pain Patches Sales & Forecasts
4.3.1 By Type - Global Non-opioid Pain Patches Sales, 2017-2022
4.3.2 By Type - Global Non-opioid Pain Patches Sales, 2023-2028
4.3.3 By Type - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
4.4 By Type - Global Non-opioid Pain Patches Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Non-opioid Pain Patches Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Independent Pharmacies & Drug Stores
5.1.4 Online Pharmacies
5.2 By Application - Global Non-opioid Pain Patches Revenue & Forecasts
5.2.1 By Application - Global Non-opioid Pain Patches Revenue, 2017-2022
5.2.2 By Application - Global Non-opioid Pain Patches Revenue, 2023-2028
5.2.3 By Application - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
5.3 By Application - Global Non-opioid Pain Patches Sales & Forecasts
5.3.1 By Application - Global Non-opioid Pain Patches Sales, 2017-2022
5.3.2 By Application - Global Non-opioid Pain Patches Sales, 2023-2028
5.3.3 By Application - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
5.4 By Application - Global Non-opioid Pain Patches Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Non-opioid Pain Patches Market Size, 2021 & 2028
6.2 By Region - Global Non-opioid Pain Patches Revenue & Forecasts
6.2.1 By Region - Global Non-opioid Pain Patches Revenue, 2017-2022
6.2.2 By Region - Global Non-opioid Pain Patches Revenue, 2023-2028
6.2.3 By Region - Global Non-opioid Pain Patches Revenue Market Share, 2017-2028
6.3 By Region - Global Non-opioid Pain Patches Sales & Forecasts
6.3.1 By Region - Global Non-opioid Pain Patches Sales, 2017-2022
6.3.2 By Region - Global Non-opioid Pain Patches Sales, 2023-2028
6.3.3 By Region - Global Non-opioid Pain Patches Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Non-opioid Pain Patches Revenue, 2017-2028
6.4.2 By Country - North America Non-opioid Pain Patches Sales, 2017-2028
6.4.3 US Non-opioid Pain Patches Market Size, 2017-2028
6.4.4 Canada Non-opioid Pain Patches Market Size, 2017-2028
6.4.5 Mexico Non-opioid Pain Patches Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Non-opioid Pain Patches Revenue, 2017-2028
6.5.2 By Country - Europe Non-opioid Pain Patches Sales, 2017-2028
6.5.3 Germany Non-opioid Pain Patches Market Size, 2017-2028
6.5.4 France Non-opioid Pain Patches Market Size, 2017-2028
6.5.5 U.K. Non-opioid Pain Patches Market Size, 2017-2028
6.5.6 Italy Non-opioid Pain Patches Market Size, 2017-2028
6.5.7 Russia Non-opioid Pain Patches Market Size, 2017-2028
6.5.8 Nordic Countries Non-opioid Pain Patches Market Size, 2017-2028
6.5.9 Benelux Non-opioid Pain Patches Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Non-opioid Pain Patches Revenue, 2017-2028
6.6.2 By Region - Asia Non-opioid Pain Patches Sales, 2017-2028
6.6.3 China Non-opioid Pain Patches Market Size, 2017-2028
6.6.4 Japan Non-opioid Pain Patches Market Size, 2017-2028
6.6.5 South Korea Non-opioid Pain Patches Market Size, 2017-2028
6.6.6 Southeast Asia Non-opioid Pain Patches Market Size, 2017-2028
6.6.7 India Non-opioid Pain Patches Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Non-opioid Pain Patches Revenue, 2017-2028
6.7.2 By Country - South America Non-opioid Pain Patches Sales, 2017-2028
6.7.3 Brazil Non-opioid Pain Patches Market Size, 2017-2028
6.7.4 Argentina Non-opioid Pain Patches Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-opioid Pain Patches Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Non-opioid Pain Patches Sales, 2017-2028
6.8.3 Turkey Non-opioid Pain Patches Market Size, 2017-2028
6.8.4 Israel Non-opioid Pain Patches Market Size, 2017-2028
6.8.5 Saudi Arabia Non-opioid Pain Patches Market Size, 2017-2028
6.8.6 UAE Non-opioid Pain Patches Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Non-opioid Pain Patches Major Product Offerings
7.1.4 Pfizer Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Non-opioid Pain Patches Major Product Offerings
7.2.4 GlaxoSmithKline Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Non-opioid Pain Patches Major Product Offerings
7.3.4 Johnson & Johnson Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Non-opioid Pain Patches Major Product Offerings
7.4.4 Novartis AG Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.4.5 Novartis AG Key News
7.5 Mylan N.V.
7.5.1 Mylan N.V. Corporate Summary
7.5.2 Mylan N.V. Business Overview
7.5.3 Mylan N.V. Non-opioid Pain Patches Major Product Offerings
7.5.4 Mylan N.V. Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.5.5 Mylan N.V. Key News
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Corporate Summary
7.6.2 Teva Pharmaceutical Industries Business Overview
7.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.6.5 Teva Pharmaceutical Industries Key News
7.7 Hisamitsu Pharmaceutical
7.7.1 Hisamitsu Pharmaceutical Corporate Summary
7.7.2 Hisamitsu Pharmaceutical Business Overview
7.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Major Product Offerings
7.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.7.5 Hisamitsu Pharmaceutical Key News
7.8 TEH SENG Pharmaceutical
7.8.1 TEH SENG Pharmaceutical Corporate Summary
7.8.2 TEH SENG Pharmaceutical Business Overview
7.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Major Product Offerings
7.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.8.5 TEH SENG Pharmaceutical Key News
7.9 Teikoku Seiyaku
7.9.1 Teikoku Seiyaku Corporate Summary
7.9.2 Teikoku Seiyaku Business Overview
7.9.3 Teikoku Seiyaku Non-opioid Pain Patches Major Product Offerings
7.9.4 Teikoku Seiyaku Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.9.5 Teikoku Seiyaku Key News
7.10 IBSA Institut Biochimque SA
7.10.1 IBSA Institut Biochimque SA Corporate Summary
7.10.2 IBSA Institut Biochimque SA Business Overview
7.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Major Product Offerings
7.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.10.5 IBSA Institut Biochimque SA Key News
7.11 Acorda Therapeutics
7.11.1 Acorda Therapeutics Corporate Summary
7.11.2 Acorda Therapeutics Non-opioid Pain Patches Business Overview
7.11.3 Acorda Therapeutics Non-opioid Pain Patches Major Product Offerings
7.11.4 Acorda Therapeutics Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.11.5 Acorda Therapeutics Key News
7.12 Allergan PLC
7.12.1 Allergan PLC Corporate Summary
7.12.2 Allergan PLC Non-opioid Pain Patches Business Overview
7.12.3 Allergan PLC Non-opioid Pain Patches Major Product Offerings
7.12.4 Allergan PLC Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.12.5 Allergan PLC Key News
7.13 Endo International
7.13.1 Endo International Corporate Summary
7.13.2 Endo International Non-opioid Pain Patches Business Overview
7.13.3 Endo International Non-opioid Pain Patches Major Product Offerings
7.13.4 Endo International Non-opioid Pain Patches Sales and Revenue in Global (2017-2022)
7.13.5 Endo International Key News
8 Global Non-opioid Pain Patches Production Capacity, Analysis
8.1 Global Non-opioid Pain Patches Production Capacity, 2017-2028
8.2 Non-opioid Pain Patches Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-opioid Pain Patches Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-opioid Pain Patches Supply Chain Analysis
10.1 Non-opioid Pain Patches Industry Value Chain
10.2 Non-opioid Pain Patches Upstream Market
10.3 Non-opioid Pain Patches Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-opioid Pain Patches Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com